Literature DB >> 9426281

ASE-1: a novel protein of the fibrillar centres of the nucleolus and nucleolus organizer region of mitotic chromosomes.

C M Whitehead1, R J Winkfein, M J Fritzler, J B Rattner.   

Abstract

A novel nucleolar component has been identified and cloned using a human autoimmune serum. This antigen, as inferred from the cDNA sequence, is an Mr 55000 protein. Immuno blot analysis, however, of both the native protein and the in vitro translation products of the cDNA showed that they migrate on SDS-PAGE at an apparent molecular mass of 90000 A BLAST search using the cDNA sequence indicated that it is in an antisense orientation to and overlaps the gene of the DNA repair enzyme ERCC-1. An open reading frame, without a translational start site, had been observed by others in this region of the chromosome 19 (19q13.3) and the putative protein was termed ASE-1 (Anti-Sense to ERCC-1). Our cDNA is a full-length equivalent of that open reading frame. ASE-1 was found to contain two domains that are present in a number of nucleolar specific proteins originating from a variety of organisms: a glycine-, arginine- and phenylalanine-rich putative nucleotide interaction domain and an alternating basic/acidic region. Indirect immunofluorescence analysis using antibodies generated to cloned regions of ASE-1 indicated that this protein occurs at the fibrillar centres of the nucleolus in interphase, the putative sites of rDNA transcription, and during cell division it is localized to the nucleolus organizer regions of the chromosomes. ASE-1 co-localises with the RNA polymerase I transcription initiation factor UBF/NOR-90 throughout all stages of the cell cycle and these two proteins associate with each other in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426281     DOI: 10.1007/s004120050271

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  14 in total

1.  Transcriptional repression mechanisms of nucleolus organizer regions (NORs) in humans and chimpanzees.

Authors:  Ana Karina Zavala Guillén; Yuriko Hirai; Tetsuya Tanoue; Hirohisa Hirai
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

2.  RNA polymerase I-specific subunit CAST/hPAF49 has a role in the activation of transcription by upstream binding factor.

Authors:  Kostya I Panov; Tatiana B Panova; Olivier Gadal; Kaori Nishiyama; Takashi Saito; Jackie Russell; Joost C B M Zomerdijk
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  ERCC1 and ERCC2 polymorphisms and adult glioma.

Authors:  Margaret Wrensch; Karl T Kelsey; Mei Liu; Rei Miike; Michelle Moghadassi; Jennette D Sison; Kenneth Aldape; Alex McMillan; Joseph Wiemels; John K Wiencke
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

Review 4.  Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others.

Authors:  Minoru Satoh; Angela Ceribelli; Tomoko Hasegawa; Shin Tanaka
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-08       Impact factor: 10.817

Review 5.  Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes.

Authors:  Sarah J Goodfellow; Joost C B M Zomerdijk
Journal:  Subcell Biochem       Date:  2013

6.  Multiple protein-protein interactions by RNA polymerase I-associated factor PAF49 and role of PAF49 in rRNA transcription.

Authors:  Kazuo Yamamoto; Mika Yamamoto; Ken-ichi Hanada; Yasuhisa Nogi; Toshifumi Matsuyama; Masami Muramatsu
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 7.  Bioinformatic analysis of the nucleolus.

Authors:  Anthony K L Leung; Jens S Andersen; Matthias Mann; Angus I Lamond
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

Review 8.  The RNA polymerase I transcription machinery.

Authors:  Jackie Russell; Joost C B M Zomerdijk
Journal:  Biochem Soc Symp       Date:  2006

9.  Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study.

Authors:  Camilla F Skjelbred; Mona Saebø; Bjørn A Nexø; Håkan Wallin; Inger-Lise Hansteen; Ulla Vogel; Elin H Kure
Journal:  BMC Cancer       Date:  2006-07-03       Impact factor: 4.430

10.  ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.

Authors:  Xiaobo Lu; Yanhua Liu; Tao Yu; Sha Xiao; Xiaoyan Bao; Liang Pan; Guolian Zhu; Yuan Cai; Qiufang Liu; Cuihong Jin; Jinghua Yang; Shengwen Wu; Li An; Tahar van der Straaten
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.